These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Chronic toxicity of 4-[3'-diethylamino-2'hydroxypropyl]-ajmaline hydrogen tartrate (Tachmalcor) in the rat]. Grimm I; Sziegoleit W; Riedel H; Förster W Pharmazie; 1976; 31(1):44-7. PubMed ID: 3809 [No Abstract] [Full Text] [Related]
5. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol]. Terhaag B; Förster W; Mest HJ; Schrör K Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278 [No Abstract] [Full Text] [Related]
6. [Poisoning with detajmium bitartrate (tachmalcor)--a case report]. Höfs T; Paul S Z Arztl Fortbild (Jena); 1985; 79(13):573-4. PubMed ID: 4036188 [No Abstract] [Full Text] [Related]
7. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects]. Femmer K; Grünheid K Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276 [No Abstract] [Full Text] [Related]
8. [Side effects of anti-arrhythmia agents aprindine and prajmalium bitartrate, in children]. Kamanaoroo H; Lunkenheimer A; Löser H; Hilgenberg F; Palm D Monatsschr Kinderheilkd; 1982 Jun; 130(6):514-5. PubMed ID: 7133010 [No Abstract] [Full Text] [Related]
9. [Oral treatment of continuous ventricular extrasystole with detajmiumbitartrate (Tachmalcor)--clinical studies on effectiveness and dose-time-effect relations including intraindividual therapy comparisons with ajmaline (Tachmalin)]. Wruck C; Hofmann H; Sziegoleit W; Förster W Z Gesamte Inn Med; 1982 Aug; 37(16):519-25. PubMed ID: 6183840 [TBL] [Abstract][Full Text] [Related]
10. Fatal poisoning with detajmium: identification of detajmium and its metabolites and artifacts by gas chromatography-mass spectrometry and quantification by high-performance liquid chromatography. Tenczer J; Lappenberg-Pelzer M; Schneider V; Demme U; Köppel C J Chromatogr B Biomed Appl; 1994 Nov; 661(1):47-53. PubMed ID: 7866551 [TBL] [Abstract][Full Text] [Related]
11. [Structure-activity relationship in various 4-substituted ajmaline derivatives]. Femmer K; Gabsch G; Braun K Pharmazie; 1976; 31(1):36-9. PubMed ID: 1257277 [No Abstract] [Full Text] [Related]
12. [The antiarrhythmic effect of intravenous 17-monochloroacetyl-ajmaline. A review of 50 treated cases]. Fiol Sala M Med Clin (Barc); 1983 Jun; 81(3):105-8. PubMed ID: 6888063 [No Abstract] [Full Text] [Related]
13. [Jaundice caused by ajmaline: pathogenetic theory concerning 5 cases]. Giani E; Cestari C; Lomazzi A; Magni S; Pioltelli P; Ratti L; Dinelli CA Clin Ter; 1981 Oct; 99(2):155-64. PubMed ID: 7318369 [No Abstract] [Full Text] [Related]
19. [Prajmalium bitartrate in the long-term treatment of hyperkinetic ventricular arrhythmias. Preliminary study]. Molinis G; Valente M; Tuniz D; Maisano G Boll Soc Ital Cardiol; 1981; 26(7):657-62. PubMed ID: 7347263 [No Abstract] [Full Text] [Related]
20. Proceedings: Relation of antiarrhythmic to inotropic activity of ajmaline and its therapeutically used derivatives N-propylajmaline and di-monochloracetylajmaline. Raschak M Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R32. PubMed ID: 1143422 [No Abstract] [Full Text] [Related] [Next] [New Search]